Margarita Rivera

Dr. Margarita Rivera

Department of Biochemistry and Molecular Biology II, Faculty of Pharmacy and Institute of Neurosciences, Biomedical Research Centre (CIBM), University of Granada, Granada, Spain

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 April 2018 in Nature Genetics
Verified
Journal Article
Open access
PDF file
NWNaomi R. Wray
Naomi R. Wray
SRStephan Ripke
Stephan Ripke
MMManuel Mattheisen
Manuel Mattheisen
MTMaciej Trzaskowski
Maciej Trzaskowski
EBEnda M. Byrne
Enda M. Byrne
EQEqtlgen
Eqtlgen
Major depressive disorder (MDD) is a common illness accompanied by considerable morbidity, mortality, costs, and heightened risk of suicide. We conducted a genome-wide association meta-analysis based in 135,458 cases and 344,901 controls and identified 44 independent and significant loci. The genetic findings were associated with clinical features of major depression and implicated brain regions exhibiting anatomical differences in cases. Targets of antidepressant medications and genes involved in gene splicing were enriched for smaller association signal. We found important relationships of genetic risk for major depression with educational attainment, body mass, and schizophrenia: lower educational attainment and higher body mass were putatively causal, whereas major depression and schizophrenia reflected a partly shared biological etiology. All humans carry lesser or greater numbers of genetic risk factors for major depression. These findings help refine the basis of major depression and imply that a continuous measure of risk underlies the clinical phenotype.

1 May 2019 in Nature Genetics
Verified
Journal Article
Open access
PDF file
ECeQTLGen Consortium
eQTLGen Consortium
ESEli A. Stahl
Eli A. Stahl
BCBIOS Consortium
BIOS Consortium
TCthe Bipolar Disorder Working Group of the Psychiatric Genomics Consortium
the Bipolar Disorder Working Group of the Psychiatric Genomics Consortium
GBGerome Breen
Gerome Breen
PSPamela Sklar
Pamela Sklar
Bipolar disorder is a highly heritable psychiatric disorder. We performed a genome-wide association study (GWAS) including 20,352 cases and 31,358 controls of European descent, with follow-up analysis of 822 variants with P < 1 × 10−4 in an additional 9,412 cases and 137,760 controls. Eight of the 19 variants that were genome-wide significant (P < 5 × 10−8) in the discovery GWAS were not genome-wide significant in the combined analysis, consistent with small effect sizes and limited power but also with genetic heterogeneity. In the combined analysis, 30 loci were genome-wide significant, including 20 newly identified loci. The significant loci contain genes encoding ion channels, neurotransmitter transporters and synaptic components. Pathway analysis revealed nine significantly enriched gene sets, including regulation of insulin secretion and endocannabinoid signaling. Bipolar I disorder is strongly genetically correlated with schizophrenia, driven by psychosis, whereas bipolar II disorder is more strongly correlated with major depressive disorder. These findings address key clinical questions and provide potential biological mechanisms for bipolar disorder.

22 June 2018 in Science
Verified
Journal Article
Open access
PDF file
TCThe Brainstorm Consortium
The Brainstorm Consortium
VAVerneri Anttila
Verneri Anttila
BBBrendan Bulik-Sullivan
Brendan Bulik-Sullivan
HFHilary K. Finucane
Hilary K. Finucane
RWRaymond K. Walters
Raymond K. Walters
BNBenjamin M. Neale
Benjamin M. Neale
Brainstorming diseases: Consistent classification of neuropsychiatric diseases is problematic because it can lead to misunderstanding of etiology. The Brainstorm Consortium examined multiple genome-wide association studies drawn from more than 200,000 patients for 25 brain-associated disorders and 17 phenotypes. Broadly, it appears that psychiatric and neurologic disorders share relatively little common genetic risk. However, different and independent pathways can result in similar clinical manifestations (e.g., psychosis, which occurs in both schizophrenia and Alzheimer's disease). Schizophrenia correlated with many psychiatric disorders, whereas the immunopathological affliction Crohn's disease did not, and posttraumatic stress syndrome was also largely independent of underlying traits. Essentially, the earlier the onset of a disorder, the more inheritable it appeared to be. Science , this issue p. eaap8757

1 December 2019 in Cell
Verified
Journal Article
Closed access
PLPhil H. Lee
Phil H. Lee
VAVerneri Anttila
Verneri Anttila
HWHyejung Won
Hyejung Won
YFYen-Chen A. Feng
Yen-Chen A. Feng
JRJacob Rosenthal
Jacob Rosenthal
JSJordan Smoller
Jordan Smoller

1 June 2018 in Cell
Verified
Journal Article
Closed access
DRDouglas M. Ruderfer
Douglas M. Ruderfer
SRStephan Ripke
Stephan Ripke
AMAndrew McQuillin
Andrew McQuillin
JBJames Boocock
James Boocock
ESEli A. Stahl
Eli A. Stahl
KKKenneth S. Kendler
Kenneth S. Kendler

1 May 2015 in Current Biology
Verified
Journal Article
Open access
NCNa Cai
Na Cai
SCSimon Chang
Simon Chang
YLYihan Li
Yihan Li
QLQibin Li
Qibin Li
JHJingchu Hu
Jingchu Hu
JFJonathan Flint
Jonathan Flint
Adversity, particularly in early life, can cause illness. Clues to the responsible mechanisms may lie with the discovery of molecular signatures of stress, some of which include alterations to an individual's somatic genome. Here, using genome sequences from 11,670 women, we observed a highly significant association between a stress-related disease, major depression, and the amount of mtDNA (p = 9.00 × 10(-42), odds ratio 1.33 [95% confidence interval [CI] = 1.29-1.37]) and telomere length (p = 2.84 × 10(-14), odds ratio 0.85 [95% CI = 0.81-0.89]). While both telomere length and mtDNA amount were associated with adverse life events, conditional regression analyses showed the molecular changes were contingent on the depressed state. We tested this hypothesis with experiments in mice, demonstrating that stress causes both molecular changes, which are partly reversible and can be elicited by the administration of corticosterone. Together, these results demonstrate that changes in the amount of mtDNA and telomere length are consequences of stress and entering a depressed state. These findings identify increased amounts of mtDNA as a molecular marker of MD and have important implications for understanding how stress causes the disease.